Key result
Transcatheter treatment using a 29-mm balloon-expandable stent successfully resolved native aortic coarctation in a 7-year-old child without complications, enabling same-day discharge.
Why the study?
Does transcatheter therapy using a balloon-expandable stent successfully and safely treat native coarctation of the aorta in a child?
Does transcatheter therapy using a balloon-expandable stent successfully and safely treat native coarctation of the aorta in a child?
Transcatheter therapy using a 29-mm balloon-expandable stent can be successfully and safely used to treat native coarctation of the aorta in a pediatric patient.
Answers are grounded in this paper and cite their sources.
May support feasibility of pediatric coarctation stenting with same-day discharge; leaves open need for prospective data on durability and generalizability.
A 7-year-old child with native coarctation of the aorta was treated by transcatheter therapy using a 29-mm balloon-expandable stent. The procedure was successful and free of complications, and the patient was discharged home the same day. This stent has several features making it uniquely advantageous for treating this condition. (Level of Difficulty: Advanced.)
No takes yet. Share an insight, caveat, or question.
Yu et al. (2023) studied this question. Transcatheter treatment using a 29-mm balloon-expandable stent successfully resolved native aortic coarctation in a 7-year-old child without complications, enabling same-day discharge.
Synapse has enriched 10 related papers. Consider them for comparative context: